Clinical trial data demonstrate that Cavhanza can be taken with or without food, offering patients greater administration convenience.

Cycle Pharmaceuticals (Cycle) announces the FDA approval of CAVHANZA (nilotinib) Orally Disintegrating Tablets. Launching ...

Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...

Omeprazole ODT utilizes MelTech technology that allows the tablet to dissolve in the mouth without water. Perrigo announced the launch of store brand Omeprazole Delayed Release Orally Disintegrating ...

Indications include newly diagnosed chronic-phase Ph+ CML and chronic/accelerated-phase disease after resistance or intolerance to prior therapy, including imatinib. Concomitant use with PPIs and ...

Drug delivery as solid dosage forms is complex with a number of factors that can noticeably influence their therapeutic benefit. The drug must be stabilized in the tablet and at the same time be ...

The US Food and Drug Administration (FDA) on Thursday issued new draft guidance covering the quality attributes drugmakers should consider when developing chewable tablets. The guidance also includes ...

Charles Ischi produces the DISI-A Touch, an automatic disintegration tester that allows the user to control all operation and data analysis using a computer and PH21 software. The system fulfils the ...

The study was conducted at a contract research organisation site (Hilltop Research, Inc., Scottsdale, AZ, USA). Healthy children from 6 to 11 years of age, with a minimum bodyweight of 16.8kg (37lbs), ...